Drugs / CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells
Follow
re-read 3 minutes ago
CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells
Cell therapy targets CD7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07345780 | Dec 2026 → Dec 2028 expected | leukocyte disorder | Donghua Zhang | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07345780 ↗ |
| Modality | Cell therapy | “CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells” NCT07345780 ↗ |
| Target | CD7 | “CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells” NCT07345780 ↗ |